Literature DB >> 915009

HBsAg, chronic lymphoproliferative disorders, and cirrhosis of liver.

R Heimann, M B Ray, V J Desmet.   

Abstract

This study reports the incidence of HBsAg in a series of chronic lymphoproliferative disorders in which a high incidence of cirrhoses had been previously observed. Twenty-three cases were collected from the necropsy records. The type of lymphoma was reviewed in the light of the new functional classifications of non-Hodgkin malignant lymphomas introduced by Lennert and Lukes. The presence of HBsAg in the liver was investigated by the indirect immunofluorescence technique. Eleven cases showed plasmocytoid features and were considered as immunocytomas. Seven cases showed cirrhosis of the liver; six of them belonged to the immunocytoma group. Four cases were positive for HBsAg. Three of them were found among the group combining cirrhosis and immunocytoma. They presented the abundant nodular distribution of HBsAg typical of inactive cirrhosis.A parallel is drawn between the often reported association of Waldenström's syndrome and cirrhosis and the association of immunocytoma and cirrhosis observed in this study. The analogy is all the more justified since most of the lymphomas associated with Waldenström's syndrome happen to be immunocytomas. Therefore the association between HB virus infection and cirrhosis on the one hand and chronic lymphoproliferative disorders on the other may not be purely coincidental. A chronic antigenic stimulus such as persisting HBsAg could trigger the proliferation of a malignant lymphoid clone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915009      PMCID: PMC476566          DOI: 10.1136/jcp.30.9.817

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  [Leukemia and the liver].

Authors:  H E BOCK; R GROSS; K LAMBERS; G WULF
Journal:  Med Nov       Date:  1959-07-25

2.  Immunologic characterization of human malignant lymphomas.

Authors:  R J Lukes; R D Collins
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

Review 3.  The immunology of liver disorders.

Authors:  G Walker
Journal:  Proc R Soc Med       Date:  1974-06

4.  Cirrhosis and lymphoproliferative disorders.

Authors:  R Heimann
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

5.  Cirrhosis and lymphoproliferative disorders.

Authors:  R Heimann
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

6.  Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders.

Authors:  A Nowoslawski; W J Brzosko; K Madaliński; K Krawczyński
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

7.  [New aspects of the pathological anatomy of leukoses].

Authors:  R Fischer
Journal:  Internist (Berl)       Date:  1968-12       Impact factor: 0.743

8.  [Cirrhosis and malignant lymphoproliferative disorders].

Authors:  R Heimann
Journal:  Acta Gastroenterol Belg       Date:  1971-10       Impact factor: 1.316

9.  Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

Authors:  F Gudat; L Bianchi; W Sonnabend; G Thiel; W Aenishaenslin; G A Stalder
Journal:  Lab Invest       Date:  1975-01       Impact factor: 5.662

10.  Immunofluorescent detection of hepatitis B antigen in paraffin-embedded liver tissue.

Authors:  M B Ray; V J Desmet
Journal:  J Immunol Methods       Date:  1975-01       Impact factor: 2.303

View more
  7 in total

1.  The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review.

Authors:  Fabrizio Marcucci; Enea Spada; Alfonso Mele; Carmelo Antonio Caserta; Alessandro Pulsoni
Journal:  Am J Blood Res       Date:  2012-01-01

2.  Autopsy case of colocalized tumors of hepatocellular carcinoma and malignant lymphoma.

Authors:  S Shikuwa; M Ito; M Nakashima; K Hamasaki; S Naito; I Sekine; H Fujii
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

3.  Pathogenic role of hepatitis B virus (HBV)

Authors:  R Heimann; L Lespagnard; V Desmet
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

4.  Malignant lymphoproliferative disorders in chronic liver disease. Report of four cases and review of the literature.

Authors:  J Naparstek; M Eliakim
Journal:  Am J Dig Dis       Date:  1978-10

5.  Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin.

Authors:  Lijuan Deng; Yuqin Song; Ken H Young; Shimin Hu; Ning Ding; Weiwei Song; Xianghong Li; Yunfei Shi; Huiying Huang; Weiping Liu; Wen Zheng; Xiaopei Wang; Yan Xie; Ningjing Lin; Meifeng Tu; Lingyan Ping; Zhitao Ying; Chen Zhang; Yingli Sun; Jun Zhu
Journal:  Oncotarget       Date:  2015-09-22

6.  [Analysis of HBV, HCV and EBV infections in diffuse large B cell lymphoma].

Authors:  X J Wu; C G Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2016-09-14

Review 7.  Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases.

Authors:  Youxi Yu; Xiaoju Shi; Xingtong Wang; Ping Zhang; Ou Bai; Yan Li
Journal:  Cell Biosci       Date:  2022-03-12       Impact factor: 7.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.